Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
JAAD Case Rep ; 16: 120-123, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34584921
2.
J Am Acad Dermatol ; 84(3): 644-653, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32561372

RESUMEN

BACKGROUND: Complications involving internal organs are usually present in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, pancreatic complications are rarely reported and studied. OBJECTIVE: To summarize clinical characteristics of SJS/TEN-associated acute pancreatic injuries and to investigate underlying inflammatory mechanisms. METHODS: Clinical records of 124 inpatients with SJS/TEN were reviewed. Serum levels of tumor necrosis factor α, interleukin (IL) 6, IL-18, IL-15, IL-12p70, and soluble CD56 were determined in 18 healthy donors and 17 patients with SJS/TEN, including 3 with acute pancreatic injuries. RESULTS: Acute pancreatic injury was diagnosed in 7.3% of patients (9/124) in the SJS/TEN cohort. Elevation of serum transaminase level and hypoalbuminemia occurred more frequently in patients with acute pancreatic injuries compared with those without pancreatic symptoms (P = .004 and <.001, respectively). Although acute pancreatic injury did not alter mortality rate of SJS/TEN, it was associated with longer hospitalization stays (P = .008). Within the serum cytokines whose levels were elevated in SJS/TEN, only IL-18 was found to be selectively increased in patients with acute pancreatic injuries compared with those without them (P = .03). LIMITATIONS: Cohort was small. CONCLUSION: Acute pancreatic injury is a gastrointestinal complication of SJS/TEN in which hepatotoxicity is more likely to occur. Overexpression of IL-18 might be involved in this unique entity.


Asunto(s)
Interleucina-18/sangre , Pancreatitis/inmunología , Síndrome de Stevens-Johnson/complicaciones , Adolescente , Adulto , Anciano , Antígeno CD56/sangre , Antígeno CD56/inmunología , Niño , Femenino , Humanos , Interleucina-12/sangre , Interleucina-12/inmunología , Interleucina-15/sangre , Interleucina-15/inmunología , Interleucina-18/inmunología , Interleucina-6/sangre , Interleucina-6/inmunología , Masculino , Persona de Mediana Edad , Pancreatitis/sangre , Estudios Retrospectivos , Síndrome de Stevens-Johnson/sangre , Síndrome de Stevens-Johnson/inmunología , Síndrome de Stevens-Johnson/mortalidad , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/inmunología , Adulto Joven
3.
J Dermatol ; 47(2): 178-180, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31829458

RESUMEN

Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder with cyclic skin eruptions during the luteal phase of the menstrual cycle. Patients can present with various clinical manifestations, including urticaria and angioedema, erythema multiforme, eczema, fixed drug eruption and centrifugal erythema annulare. In our case, however, the patient's skin lesions mimic necrotic migratory erythema (NME) which is most commonly associated with glucagonoma and rarely with liver disease, inflammatory bowel disease, malnutrition and other tumors. To our knowledge, this is the first case of NME-like APD and is successfully controlled by danazol. This also sheds lights on the etiologic diversity of NME.


Asunto(s)
Enfermedades Autoinmunes/diagnóstico , Danazol/uso terapéutico , Dermatitis/diagnóstico , Antagonistas de Estrógenos/uso terapéutico , Eritema Necrolítico Migratorio/diagnóstico , Progesterona/efectos adversos , Adulto , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades Autoinmunes/inmunología , Dermatitis/complicaciones , Dermatitis/tratamiento farmacológico , Dermatitis/inmunología , Diagnóstico Diferencial , Femenino , Glucagonoma/complicaciones , Glucagonoma/diagnóstico , Humanos , Eritema Necrolítico Migratorio/tratamiento farmacológico , Eritema Necrolítico Migratorio/inmunología , Neoplasias Pancreáticas/complicaciones , Neoplasias Pancreáticas/diagnóstico , Progesterona/inmunología , Piel/inmunología , Piel/patología , Pruebas Cutáneas , Resultado del Tratamiento
4.
Chin Med J (Engl) ; 130(22): 2703-2708, 2017 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-29133759

RESUMEN

BACKGROUND: Halo nevus (HN) has been shown to be associated with vitiligo, but no standard signs are currently available to identify HN patients at risk of vitiligo, and the relevant data obtained in previous studies are somewhat conflicting. This study aimed to identify factors affecting the presence of vitiligo in HN patients. METHODS: We performed a retrospective study on consecutive patients with HN at the First Affiliated Hospital of Sun Yat-sen University between January 2011 and December 2016. Detailed demographic and clinical data were collected to identify the factors associated with the presence of vitiligo in this cohort of patients using uni- and multi-variate logistic regression analyses. RESULTS: A total of 212 HN patients were included, 101 of whom had vitiligo-associated HN (HNV). Univariate analysis indicated that a personal history of thyroid diseases was positively associated with HNV (odds ratio [OR] = 10.761, P = 0.025), while the onset age of HN was negatively associated with HNV (OR = 0.537, P = 0.026). Multivariate analysis demonstrated that the Koebner phenomenon (KP; OR = 10.632, P < 0.0001), multiple HN (OR = 3.918, P < 0.0001), and a familial history of vitiligo (OR = 3.222, P = 0.014) were independent factors associated with HNV. CONCLUSIONS: HN without vitiligo has clinical features distinct from HN associated with vitiligo. HN patients with KP, multiple lesions, or familial history of vitiligo are more likely to develop vitiligo and therefore should be monitored for clinical signs of such accompanied conditions.


Asunto(s)
Nevo con Halo/complicaciones , Vitíligo/etiología , Adolescente , Adulto , Edad de Inicio , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nevo con Halo/patología , Estudios Retrospectivos , Factores de Riesgo , Vitíligo/patología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA